Anzeige
Mehr »
Login
Donnerstag, 23.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Amazon investiert Millionen in Kernenergie - so können Sie sich früh positionieren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DNM8 | ISIN: US71910P2039 | Ticker-Symbol:
NASDAQ
22.01.25
21:57 Uhr
0,263 US-Dollar
0,000
0,00 %
Branche
Fahrzeuge
Aktienmarkt
Sonstige
1-Jahres-Chart
PHOENIX MOTOR INC Chart 1 Jahr
5-Tage-Chart
PHOENIX MOTOR INC 5-Tage-Chart
ACCESS Newswire
188 Leser
Artikel bewerten:
(1)

Phoenix Motor Inc.: Phoenix Motor Appoints Tony Zhou as Chief Technology Officer

Finanznachrichten News

ANAHEIM, CA / ACCESS Newswire / January 23, 2025 / Phoenix Motor Inc. (NASDAQ:PEV), a leading manufacturer of heavy-duty transit buses and electrification solutions provider for medium-duty vehicles, today announced the appointment of Tony Zhou as its new Chief Technology Officer (CTO), effective January 20, 2025.

Zhou brings more than two decades of expertise in autonomous driving and artificial intelligence (AI) to Phoenix Motor. His extensive experience spans advanced driver-assistance systems (ADAS), autonomous vehicle (AV) development, and groundbreaking AI technologies. Before joining Phoenix Motor, Zhou served as Head of ADAS Advanced Software Engineering and Autonomous Driving Strategy Development at Lucid Motors, where he led the design and implementation of next-generation autonomous driving technologies, including ASIL D lane-level localization and AI-based dynamic driving systems. His achievements include multiple patents in the AV field and leadership roles in high-profile projects at global OEMs such as General Motors and FAW.

At Phoenix Motor, Zhou will spearhead the development and delivery of next-generation autonomous driving buses and commercial EVs. He takes over the CTO role from Dr. Frank Lee, who will continue serving as Vice President of Engineering until his planned retirement in six months.

"We are thrilled to welcome Tony to Phoenix Motor as our Chief Technology Officer," said Denton Peng, CEO of Phoenix Motor. "Tony's visionary leadership and proven track record in autonomous driving and AI perfectly align with our mission to revolutionize the commercial EV sector. His appointment marks a pivotal step in our journey to deliver innovative, sustainable transportation solutions."

Dr. Frank Lee, who will continue as VP Engineering until his retirement in mid-2025, expressed his support for the leadership transition: "Tony's extensive knowledge and experience will ensure a seamless handover of responsibilities. I am confident he will elevate Phoenix Motor's technological capabilities to new heights."

Zhou holds 10 patents in advanced autonomous driving technologies, with several more in progress. Notably, he previously served as Senior Vice President of Autonomous Driving at Phoenix Motors during its public offering in 2021, where he played a pivotal role in developing the company's ADAS AV roadmap. Zhou earned his Ph.D. and master's degree in electrical engineering from Wayne State University.

About Phoenix Motor Inc.
Phoenix Motor, a pioneer in the electric vehicle ("EV") industry, designs, builds, and integrates electric drive systems and manufactures heavy duty transit buses and medium and light duty commercial EVs. Phoenix operates two primary brands, "Phoenix", which is focused on commercial products including heavy and medium duty EVs (transit buses, shuttle buses, school buses and delivery trucks, among others) and "EdisonFuture", which intends to offer light-duty EVs. Phoenix endeavors to be a leading designer, developer and manufacturer of electric vehicles and electric vehicle technologies. To learn more, please visit: phoenixev.ai.

Forward-Looking Statements
This press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995, that involve significant risks and uncertainties. Forward-looking statements can be identified through the use of words such as "may," "might," "will," "intend," "should," "could," "can," "would," "continue," "expect," "believe," "anticipate," "estimate," "predict," "outlook," "potential," "plan," "seek," and similar expressions and variations or the negatives of these terms or other comparable terminology. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect the Company's current expectations and speak only as of the date of this release. Actual results may differ materially from the Company's current expectations depending upon a number of factors. These risk factors include, among others, those related to our ability to raise additional capital necessary to grow our business, operations and business and financial performance, our ability to grow demand for our products and revenue, our ability to become profitable, our ability to have access to an adequate supply of parts and materials and other critical components for our vehicles on the timeline we expect, the coronavirus (COVID-19) and the effects of the outbreak and actions taken in connection therewith, adverse changes in general economic and market conditions, competitive factors including but not limited to pricing pressures and new product introductions, uncertainty of customer acceptance of new product offerings and market changes, risks associated with managing the growth of the business, and those other risks and uncertainties that are described in the "Risk Factors" section of the Company's annual report filed on Form 10-K filed with the Securities and Exchange Commission. Except as required by law, the Company does not undertake any responsibility to revise or update any forward-looking statements.

CONTACT:

IR@phoenixev.ai
Dave Gentry, CEO
RedChip Companies, Inc.
1-407-644-4256
PEV@redchip.com

SOURCE: Phoenix Motor Inc.



View the original press release on ACCESS Newswire

© 2025 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.